Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial
Authors not in graph record · peer-reviewed
Study design and participants
- Design
- not reported
- Sample size
- not reported
- Population
- adults
- Intervention and protocol
- ~1 g/day
Results
Study-specific results are not reported in the structured record.
Limitations, bias, and funding
Risk of bias: not assessed
Funding: not reported
- No structured study appraisal is available.